BIOSPECIFICS TECHNOLOGIES CORP - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 - May 11, 2020

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - BIOSPECIFICS TECHNOLOGIES CORPex31_2.htm
EX-31.1 - EXHIBIT 31.1 - BIOSPECIFICS TECHNOLOGIES CORPex31_1.htm
EX-10.6 - EXHIBIT 10.6 - BIOSPECIFICS TECHNOLOGIES CORPex10_6.htm
EX-10.5 - EXHIBIT 10.5 - BIOSPECIFICS TECHNOLOGIES CORPex10_5.htm
EX-10.4 - EXHIBIT 10.4 - BIOSPECIFICS TECHNOLOGIES CORPex10_4.htm
EX-10.3 - EXHIBIT 10.3 - BIOSPECIFICS TECHNOLOGIES CORPex10_3.htm
EX-10.2 - EXHIBIT 10.2 - BIOSPECIFICS TECHNOLOGIES CORPex10_2.htm
10-Q - 10-Q - BIOSPECIFICS TECHNOLOGIES CORPform10q.htm
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioSpecifics Technology Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, J. Kevin Buchi, Principal Executive Officer of the Company, and Patrick Hutchison, Principal Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on each of our knowledge:


 1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and


2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  May 11, 2020

 
/s/ Joseph Truitt
 
Joseph Truitt
 
Principal Executive Officer
   
 
/s/ Patrick Hutchison
 
Patrick Hutchison
 
Principal Financial Officer




Stock widget

Investing forum

BIOSPECIFICS TECHNOLOGIES CORP Reports